Blocking PD1 with anti-PD1 antibody increased the levels of tumor-infiltrating T cells and NK cells in B16F10 tumor-bearing mice with intravenous treatment with JCXH-211 compared to the mice with control treatment (Fig. 5G,H). Here, PDCD1 is linked to neoplasm.